In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Influence of metabolic or infection disease on the heart
Session

Event : ESC Congress 2019

Topic : Cardiovascular Disease in Special Populations

  • Session type : Rapid Fire Abstracts
  • Date : 02 September 2019
  • Time : 18:40 - 19:50

7 presentations in this session

Left ventricular myocardial mass index is a predictor of clinical outcomes in patients with Fabry disease

Event : ESC Congress 2019

  • Session : Influence of metabolic or infection disease on the heart
  • Speaker : S Moiseev (Moscow,RU)

Decreased CD177 expression and its association with intravenous immunoglobulin resistance in Kawasaki disease

Event : ESC Congress 2019

  • Session : Influence of metabolic or infection disease on the heart
  • Speaker : Y Huang (Kaohsiung City,TW)

Left ventricular systolic function in patients with systemic lupus erythematosus and its association with cardiovascular events

Event : ESC Congress 2019

  • Session : Influence of metabolic or infection disease on the heart
  • Speaker : T Gegenava (Leiden,NL)

Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia

Event : ESC Congress 2019

  • Session : Influence of metabolic or infection disease on the heart
  • Speaker : T Leucker (Baltimore,US)

Cardiac involvement of Wilsons disease

Event : ESC Congress 2019

  • Session : Influence of metabolic or infection disease on the heart
  • Speaker : U Speiser (Dresden,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are